Lantus is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Sanofi-aventis U.s. Llc. The primary component is Insulin Glargine.
Product ID | 0088-5021_2c27943b-b9d7-4838-8b39-618aab8b54fa |
NDC | 0088-5021 |
Product Type | Human Prescription Drug |
Proprietary Name | Lantus |
Generic Name | Insulin Glargine |
Dosage Form | Injection, Solution |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 2017-06-04 |
Marketing Category | BLA / NDA |
Application Number | BLA021081 |
Labeler Name | sanofi-aventis U.S. LLC |
Substance Name | INSULIN GLARGINE |
Active Ingredient Strength | 100 [iU]/mL |
Pharm Classes | Insulin [Chemical/Ingredient],Insulin Analog [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2017-06-04 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA021081 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2017-06-04 |
Ingredient | Strength |
---|---|
INSULIN GLARGINE | 100 [iU]/mL |
SPL SET ID: | 6328c99d-d75f-43ef-b19e-7e71f91e57f6 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
PHarm Class EPC | |
NUI Code |
NDC | Brand Name | Generic Name |
---|---|---|
0088-2220 | Lantus | insulin glargine |
70518-1865 | Lantus | Lantus |
0088-5021 | Lantus | Lantus |
50090-0876 | Lantus | Lantus |
55045-3685 | Lantus | Lantus |
64725-2220 | Lantus | Lantus |
0002-7715 | BASAGLAR | Insulin glargine |
0002-8214 | BASAGLAR | Insulin glargine |
0088-2219 | Lantus Solostar | insulin glargine |
0024-5869 | TOUJEO | insulin glargine |
0024-5871 | TOUJEO Max | insulin glargine |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
LANTUS 87583887 not registered Live/Pending |
SIG SAUER Inc. 2017-08-25 |
LANTUS 74436868 2183182 Live/Registered |
SANOFI-AVENTIS DEUTSCHLAND GMBH 1993-09-17 |